Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Declines in unintended pregnancy in the United States, 2008-2011.N Engl J Med. 2016; 374: 843-852https://doi.org/10.1056/NEJMsa1506575
- https://www.guttmacher.org/report/publicly-funded-family-planning-clinic-survey-2015. (accessed August 12, 2022)
U.S. Department of Health and Human Services. Healthy people 2030; https://health.gov/healthypeople. (accessed August 12, 2022).
- Over-the-counter access to hormonal contraception: ACOG committee opinion, number 788.Obstet Gynecol. 2019; 134: e96-105https://doi.org/10.1097/AOG.0000000000003473
American Medical Association. Over-the-counter access to oral contraceptives D-75.995 (modified resolution 518-A-22), 2022; https://policysearch.ama-assn.org/policyfinder/detail/D-75.995?uri=%2FAMADoc%2Fdirectives.xml-0-2035.xml. (accessed August 12, 2022).
- Modeling the impacts of price of an over-the-counter progestin-only pill on use and unintended pregnancy among U.S. women.Womens Health Issues. 2020; 30: 153-160https://doi.org/10.1016/j.whi.2020.01.003
- 2013-2015 National Survey of Family Growth.Centers for Disease Control and Prevention, Atlanta2016
- Interest in over-the-counter access to a progestin-only pill among women in the United States.Womens Health Issues. 2018; 28: 144-151https://doi.org/10.1016/j.whi.2017.11.006
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT04112095, Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use (ACCESS); https://clinicaltrials.gov/ct2/show/NCT04112095. (accessed August 12, 2022).
- Efficacy, safety, and personal considerations.(editors)in: Kowal D Hatcher RA Nelson AL Trussell J Cwiak C Cason P Contraceptive technology. 21st edition. Managing Contraception LLC, New York2018
National Center for Health Statistics. 2017-2019 National Survey of Family Growth Public-Use Data and Documentation. Hyattsville, MD: CDC National Center for Health Statistics. https://www.cdc.gov/nchs/nsfg/nsfg_2017_2019_puf.htm. (accessed August 12, 2022)
- Continuation of prescribed compared with over-the-counter oral contraceptives.Obstet Gynecol. 2011; 117: 551-557https://doi.org/10.1097/AOG.0b013e31820afc46
- Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.Contraception. 2008; 78: 271-283https://doi.org/10.1016/j.contraception.2008.05.007
- Potential public sector cost-savings from over-the-counter access to oral contraceptives.Contraception. 2015; 91: 373-379https://doi.org/10.1016/j.contraception.2015.01.010
- The intensive and extensive margins of contraceptive use: comparing the effects of method choice and method initiation.Contraception. 2016; 94: 160-167https://doi.org/10.1016/j.contraception.2016.03.014
- Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial.Obstet Gynecol. 2012; 119: 14-20https://doi.org/10.1097/AOG.0b013e31823d4167
- Progestin-only pills.(editors)in: Kowal D Hatcher RA Nelson AL Trussell J Cwiak C Cason P Contraceptive technology. 21st edition. Managing Contraception LLC, New York2018: 317-328
- Global contraceptive failure rates: who is most at risk?.Stud Fam Plann. 2019; 50: 3-24https://doi.org/10.1111/sifp.12085
- One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives.Obstet Gynecol. 2011; 117: 363-371https://doi.org/10.1097/AOG.0b013e31820563d3
- Rapid estimate of adult literacy in medicine: a shortened screening instrument.Fam Med. 1993; 25 (PMID: 8349060): 391-395
- Development and validation of the Rapid Estimate of Adolescent Literacy in Medicine (REALM-Teen): a tool to screen adolescents for below-grade reading in health care settings.Pediatrics. 2006; 118 (PMID: 17142495): e1707-e1714https://doi.org/10.1542/peds.2006-1139
Conflicts of interest: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: I Laurora and H Guillard are employees of HRA Pharma. S Sober, A Karapet, E Brass and A Glasier serve as consultants to HRA Pharma.
Funding: This work was fully funded by Laboratoire HRA Pharma.
User licenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy